Cell Therapy News/Articles, page-2876

If you're a trader or a new buyer, only invested for the Covid ARDS opportunity and bought at a higher SP then I can understand your sentiment however there is so much going on beyond Covid which basically came out of the blue and created an extra opportunity for the company. The article above with Grossman highlights the pipeline. But I invested a long time before Covid and have a long horizon for this one, thus my angle. If you're not long though you could possibly pull out now with the hope of a southward SP and buy back in a few weeks or so to increase your holding or buy the same cheaper. It's a risk though and most certainly not financial advice

Everyone has to make their own decisions around their capital.